Majic: A Phase 3 Prospective, Multicenter, Randomized, Open-Label Trial of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Davids, Matthew S., Mato, Anthony R., Hum, Juliette, Wargo, Susana, Emeribe, Ugochinyere, Shahkarami, Mina, Sokolowski, Kevin, Biondo, Juliana M.L., Abhyankar, Sarang, Hermann, Rick, Sharman, Jeff P.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article